US Pharma MarketingExclusive: House China panel questions Bristol Myers, Pfizer on trial sites
House China panel probes Bristol Myers, Pfizer over clinical trial sites tied to the Chinese military and Xinjiang amid scrutiny of pharma Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push…
A congressional committee has opened an inquiry into Bristol Myers Squibb and Pfizer's use of clinical trial sites in China, including facilities that the committee's chairman said are affiliated with the Chinese military or that ...
Source: Endpoints News